服务热线:400-028-9008
您好!欢迎访问图拉扬公司![登录] [注册]
我的订单

当前位置:首页 > 新闻资讯 > 科学前沿 > 葡萄糖驱动的人工神经免疫轴用于代谢调控
文章导读
新加坡国立大学Liu, Yuxin课题组在研究中取得进展。他们研制了葡萄糖驱动的人造神经免疫轴,用于代谢控制。2026年11月18日,国际知名学术期刊《自然》发表了这一成果。

新加坡国立大学Liu, Yuxin课题组在研究中取得进展。他们研制了葡萄糖驱动的人造神经免疫轴,用于代谢控制。2026年11月18日,国际知名学术期刊《自然》发表了这一成果。

 

在这里,小组报告人工神经免疫轴(NeuroAxis)作为治疗代谢性疾病的闭环免疫调节疗法。神经轴与生物上的同类产品类似,完全由内源性葡萄糖提供动力,无需电池或无线传输。它通过代谢内感受反馈的闭环神经调节来模拟迷走反射。在1型糖尿病大鼠模型中,NeuroAxis促进产生胰岛素的胰腺β细胞的恢复,并减少炎症免疫反应;在2型糖尿病大鼠模型中,它可以驱动巨噬细胞重塑并减少全身慢性炎症。在两种模型中,NeuroAxis均能恢复葡萄糖耐量,改善胰岛素敏感性,使血糖控制正常化,治疗效果在停止治疗后仍持续存在。他们的人工神经免疫轴促进了代谢紊乱治疗的实质性进展,并代表了自主调节器官间通讯的一般方法,对体内平衡和病理生理学至关重要。

研究人员表示,糖尿病等代谢性疾病是由代谢失衡、慢性炎症和神经免疫轴功能障碍引起的全球性健康危机。针对自主神经系统的电药已经显示出抗炎作用,但现有系统缺乏代谢内感受反馈来完全恢复免疫代谢稳态。

附:英文原文

Title: A glucose-powered artificial neuroimmune axis for metabolic control

Author: Xiu, Weijun, Wang, Qian, Wan, Ling, Liang, Zhuoming, Panganiban, Michael Raphael, Li, Xiaoye, He, Ao, Zhang, Yu, Dong, Heng, Fu, Yu, Wang, Lianhui, Liu, Yuxin

Issue&Volume: 2026-11-18

Abstract: Metabolic disorders such as diabetes mellitus are global health crises driven by metabolic imbalance, chronic inflammation and dysfunction of the neuroimmune axis1,2,3. Electroceuticals targeting the autonomic nervous system have shown anti-inflammatory effects, yet existing systems lack the metabolic interoceptive feedback to fully restore immune–metabolic homeostasis4,5,6,7,8,9. Here we report an artificial neuroimmune axis (NeuroAxis) as a closed-loop immunomodulatory therapy for treating metabolic diseases. Analogous to its biological counterpart, NeuroAxis is solely powered by endogenous glucose, operating without batteries or wireless power transfer. It emulates the vagal reflex through closed-loop neuromodulation with metabolic interoceptive feedback. In a rat model of type 1 diabetes, NeuroAxis promotes the recovery of insulin-producing pancreatic β-cells and reduces inflammatory immune responses; in a rat model of type 2 diabetes, it drives macrophage remodelling and reduces systemic chronic inflammation. In both models, NeuroAxis restores glucose tolerance, improves insulin sensitivity and normalizes glycaemic control, with therapeutic effects persisting after treatment cessation. Our artificial neuroimmune axis promotes substantial advances in treating metabolic disorders and represents a general approach for autonomously regulating interorgan communication, central to homeostasis and pathophysiology.

DOI: 10.1038/s41586-026-11251-7

Source: https://www.nature.com/articles/s41586-026-11251-7

期刊信息

Nature:《自然》,创刊于1869年。隶属于施普林格·自然出版集团,最新IF:69.504
官方网址:http://www.nature.com/
投稿链接:http://www.nature.com/authors/submit_manuscript.html



*本文内容非商业广告,仅供专业人士参考!